跳至主導覽 跳至搜尋 跳過主要內容

Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways

  • Sarinya Kongpetch
  • , Apinya Jusakul
  • , Choon Kiat Ong
  • , Weng Khong Lim
  • , Steven G. Rozen
  • , Patrick Tan
  • , Bin Tean Teh*
  • *此作品的通信作者
  • National Cancer Centre
  • Khon Kaen University
  • National University of Singapore
  • Duke-NUS Medical School
  • Agency for Science, Technology and Research, Singapore

研究成果: 期刊稿件 › 文獻綜述 › 同儕審查

48 引文 斯高帕斯(Scopus)

摘要

Abstract Cholangiocarcinoma (CCA) is a malignant tumour of bile duct epithelial cells with dismal prognosis and rising incidence. Chronic inflammation resulting from liver fluke infection, hepatitis and other inflammatory bowel diseases is a major contributing factor to cholangiocarcinogenesis, likely through accumulation of serial genetic and epigenetic alterations resulting in aberration of oncogenes and tumour suppressors. Recent studies making use of advances in high-throughput genomics have revealed the genetic landscape of CCA, greatly increasing our understanding of its underlying biology. A series of highly recurrent mutations in genes such as TP53, KRAS, SMAD4, BRAF, MLL3, ARID1A, PBRM1 and BAP1, which are known to be involved in cell cycle control, cell signalling pathways and chromatin dynamics, have led to investigations of their roles, through molecular to mouse modelling studies, in cholangiocarcinogenesis. This review focuses on the landscape genetic alterations in CCA and its functional relevance to the formation and progression of CCA.

原文英語
文章編號1327
頁(從 - 到)233-244
頁數12
期刊Best Practice and Research: Clinical Gastroenterology
卷29
發行號2
DOIs
出版品狀態已出版 - 01 04 2015
對外發佈是

文獻附註

Publisher Copyright:
© 2015 Elsevier Ltd.

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG3 健康與福祉
    SDG3 健康與福祉

指紋

深入研究「Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways」主題。共同形成了獨特的指紋。

引用此